RIA
TEVA icon

Richwood Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Richwood Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,243
Closed -$10K – 233
2021
Q4 		$10K Buy
+1,243
New +$11.2K 0.01% 237

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Richwood Investment Advisors's TEVA Position: Q1 2022 in Review

Richwood Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2022, closing a stake of 1,243 shares — an estimated $10K sold.

Richwood Investment Advisors first reported a position in TEVA in Q4 2021 and held it in 1 quarter. The position peaked at $10K in Q4 2021. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.

  • Richwood Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Richwood Investment Advisors sold 1,243 Teva Pharmaceuticals shares in Q1 2022, an estimated $10K.
  • Richwood Investment Advisors first reported a position in Teva Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Richwood Investment Advisors's Teva Pharmaceuticals position peaked at $10K in Q4 2021.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2022.

Based on Richwood Investment Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.